Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06192927 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of TenoMiR in Lateral Epicondylitis
A Phase 2 study of Tennis Elbow, sponsored by Causeway Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 123
- Enrollment target
- 9
- Study locations
NCT06192927 is a Phase 2 study of Tennis Elbow that has completed, run by Causeway Therapeutics. The registered enrollment target is 123 participants, above the 96-participant average among 3 other Tennis Elbow trials with a reported enrollment target (28% higher). The trial reports 9 study locations across 3 states.
The verdict
NCT06192927, a Phase 2 study of Tennis Elbow, has completed, sponsored by Causeway Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 123 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of providing a more reliable treatment than those currently available and can be given at the time of first diagnosis, so that recovery can begin as soon as possible. The study drug has been tested in humans in an earlier study, and appeared to be safe and well-tolerated. This study aims to test the study drug in a larger number of participants.
Conditions Studied
Interventions
- DRUG 0.9% Sodium Chloride Injection
- DRUG TenoMiR
Study Locations (9)
Other
- Panthera Biopartners - Enfield
- Panthera Biopartners - Glasgow
- Glasgow Clinical Research Facility - Glasgow
- Panthera Biopartners - Preston
- Panthera Biopartners - Rochdale
- Panthera Biopartners - Sheffield
New York
- Hospital for Special Surgery - New York
- NYU Langone Health - New York
California
- Stanford Medicine - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2025-06-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06192927
The ClinicalTrials.gov registry entry for NCT06192927 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 3 other Tennis Elbow trials with a reported enrollment target (28% higher). The listed sponsor is Causeway Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tennis Elbow appearing as the primary indexed condition, and to 2 interventions - of which 0.9% Sodium Chloride Injection is the first listed.
NCT06192927 reports 9 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, California.
Frequently Asked Questions
What is clinical trial NCT06192927 about?
NCT06192927 is a clinical study titled "Efficacy and Safety of TenoMiR in Lateral Epicondylitis". This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of...
What is the current status of trial NCT06192927?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 123 participants. The study started on 2024-04-10. Estimated completion is 2025-06-12.
What conditions does trial NCT06192927 study?
This clinical trial studies the following conditions: Tennis Elbow.
What interventions are being tested in trial NCT06192927?
The interventions under investigation include: 0.9% Sodium Chloride Injection (DRUG), TenoMiR (DRUG).
Who is sponsoring clinical trial NCT06192927?
This trial is sponsored by Causeway Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06192927 being conducted?
This trial has 9 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tennis Elbow
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.